Wellington Management Group
BDTX icon

Wellington Management Group’s Black Diamond Therapeutics BDTX Stock Holding History

Wellington Management Group’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-221,236
Closed -$473K – 1949
2024
Q4 		$473K Buy
221,236
+16,279
+8% +$46.7K ﹤0.01% 1839
2024
Q3 		$892K Buy
204,957
+23,282
+13% +$127K ﹤0.01% 1733
2024
Q2 		$847K Buy
181,675
+15,989
+10% +$85.8K ﹤0.01% 1709
2024
Q1 		$840K Buy
+165,686
New +$668K ﹤0.01% 1721
2021
Q3 		– Sell
-25,977
Closed -$316K – 2150
2021
Q2 		$316K Sell
25,977
-570,569
-96% -$11.3M ﹤0.01% 2020
2021
Q1 		$14.5M Sell
596,546
-557,282
-48% -$15M ﹤0.01% 1147
2020
Q4 		$37M Buy
1,153,828
+24,536
+2% +$806K 0.01% 858
2020
Q3 		$34.1M Sell
1,129,292
-214,505
-16% -$6.53M 0.01% 801
2020
Q2 		$56.5M Buy
1,343,797
+78,899
+6% +$2.9M 0.01% 670
2020
Q1 		$31.1M Buy
+1,264,898
New +$38.5M 0.01% 762

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Wellington Management Group's BDTX Position: Q1 2025 in Review

Wellington Management Group sold out of Black Diamond Therapeutics (BDTX) in Q1 2025, closing a stake of 221,236 shares — an estimated $473K sold.

Wellington Management Group first reported a position in BDTX in Q1 2020 and held it in 10 quarters. The position peaked at $56.5M in Q2 2020. 84 funds tracked by Wall St. Rank hold BDTX as of Q1 2025.

  • Wellington Management Group reported no remaining Black Diamond Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Wellington Management Group sold 221,236 Black Diamond Therapeutics shares in Q1 2025, an estimated $473K.
  • Wellington Management Group first reported a position in Black Diamond Therapeutics in Q1 2020 and held it in 10 quarters.
  • Wellington Management Group's Black Diamond Therapeutics position peaked at $56.5M in Q2 2020.
  • 84 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2025.

Based on Wellington Management Group's 13F filing for Q1 2025, filed 13 May 2025.